Key result
Natural PCSK9 inhibitors show potential as emerging antiviral therapies across multiple viral diseases.
Answers are grounded in this paper and cite their sources.
This review explores the potential role of natural compounds as PCSK9 inhibitors in the context of antiviral therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kareem et al. (2026) conducted a review in Viral diseases and cardiovascular disease. Natural compounds as PCSK9 inhibitors was evaluated. Emerging evidence implicates PCSK9 in the pathophysiology of several viral diseases, highlighting the potential of natural compounds as PCSK9 inhibitors for antiviral therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: